Israel Englander Astria Therapeutics, Inc. Transaction History

Millennium Management LLC

$192 Billion
Q2 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Astria Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 2,969,727 shares of ATXS stock, worth $19.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,969,727

Previous 1,634,155 81.73%

Holding current value

$19.7 Million

Previous $8.73 Million 82.41%

% of portfolio

0.01%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$3.75 - $5.99 $5.01 Million - $8 Million	1,335,572 Added 81.73%	2,969,727 $15.9 Million
Q1 2025 May 15, 2025	SELL	$5.34 - $9.1 $1.55 Million - $2.64 Million	-290,348 Reduced 15.09%	1,634,155 $8.73 Million
Q4 2024 Feb 14, 2025	SELL	$8.81 - $12.1 $4.95 Million - $6.8 Million	-561,683 Reduced 22.59%	1,924,503 $17 Million
Q3 2024 Nov 14, 2024	BUY	$8.97 - $12.65 $5.78 Million - $8.15 Million	644,123 Added 34.97%	2,486,186 $27.4 Million
Q2 2024 Aug 14, 2024	BUY	$8.83 - $13.51 $1.54 Million - $2.36 Million	174,318 Added 10.45%	1,842,063 $16.8 Million
Q1 2024 May 15, 2024	BUY	$6.99 - $16.69 $10.1 Million - $24.2 Million	1,447,611 Added 657.6%	1,667,745 $23.5 Million
Q4 2023 Feb 14, 2024	SELL	$4.42 - $8.06 $249,897 - $455,696	-56,538 Reduced 20.44%	220,134 $1.69 Million
Q2 2023 Aug 14, 2023	SELL	$8.33 - $13.72 $145,108 - $239,002	-17,420 Reduced 5.92%	276,672 $2.3 Million
Q1 2023 May 15, 2023	BUY	$11.2 - $15.79 $1.97 Million - $2.77 Million	175,466 Added 147.92%	294,092 $3.91 Million
Q4 2022 Feb 14, 2023	BUY	$7.44 - $14.89 $728,495 - $1.46 Million	97,916 Added 472.8%	118,626 $1.77 Million
Q3 2022 Nov 14, 2022	BUY	$2.97 - $10.34 $11,265 - $39,219	3,793 Added 22.42%	20,710 $187,000

Others Institutions Holding ATXS

# of Institutions

110

Shares Held

49.3M

Call Options Held

6.6K

Put Options Held

View Full List

About Astria Therapeutics, Inc.

Ticker ATXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,178,000
Market Cap $101M
Description
Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...

More about ATXS

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account